Financial statements Apteka 36,6
Balance sheet data of APTEKA 36,6
|
Year
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|---|
| Total assets | 2 486 367,69 | 2 938 996,96 | 3 017 262,71 | 3 104 816,37 | 1 646 327,04 | 3 059 060,96 | 4 370 222,82 |
| A. Fixed assets | 748 625,55 | 622 978,89 | 390 261,35 | 324 442,02 | 181 227,31 | 534 454,99 | 466 770,50 |
| B. Current assets | 1 737 742,14 | 2 316 018,07 | 2 627 001,36 | 2 780 374,35 | 1 465 099,73 | 2 524 605,97 | 3 903 452,32 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 486 367,69 | 2 938 996,96 | 3 017 262,71 | 3 104 816,37 | 1 646 327,04 | 3 059 060,96 | 4 370 222,82 |
| A. Equity | -8 422 609,48 | 1 405 772,93 | 367 504,97 | 220 127,00 | -165 746,84 | 629 152,53 | 1 312 561,51 |
| B. Liabilities and provisions for liabilities | 10 908 977,17 | 1 533 224,03 | 2 649 757,74 | 2 884 689,37 | 1 812 073,88 | 2 429 908,43 | 3 057 661,31 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 10 874 462,10 | 1 483 043,44 | 2 605 104,19 | 2 814 759,91 | 1 744 370,97 | 2 317 338,12 | 2 944 425,12 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.